1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Algeria Pharmaceuticals and Healthcare Report Q3 2016

Algeria Pharmaceuticals and Healthcare Report Q3 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 92 pages

Includes 3 FREE quarterly updates

BMI View: The Algerian pharmaceutical market will remain attractive to multinational drugmakers,despite the slow pace of improvements in the regulatory and market access environment. Key marketdrivers such as growing demand for healthcare, rising chronic disease burden and sustained foreigninvestment in domestic drug manufacturing will continue to translate in strong market growth rates over theforecast period. Despite short-term economic and fiscal challenges, developing Algeria's pharmaceuticalindustry will remain a policy priority and therefore benefit from government incentives. This will remain inline with the broader interest by foreign drugmakers to sustain the country's ongoing plan to become aregional hub in pharmaceutical production.

Headline Expenditure Projections

- Pharmaceuticals: DZD411.62bn (USD4.12bn) in 2015 to DZD451.90bn (USD4.13bn) in 2016; +9.8%in local currency and +0.3% in US dollar terms.


Forecast in line with last quarter

- Healthcare: DZD1.11trn (USD11.14bn) in 2015 to DZD1.20trn (USD11.00bn) in 2016; +8.2% in localcurrency and -1.2% in US dollar terms. Forecast in line with last quarter.

Table Of Contents

Algeria Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Algeria 2014-2020) 7
SWOT 10
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Algeria 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Algeria 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Algeria 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Algeria 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Algeria 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Algeria 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Algeria 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Algeria 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Algeria 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Algeria 2014-2020) 29
Industry Risk/Reward Index 30
Middle East and Africa Risk/Reward Index - Q3 2016 30
Algeria Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 40
Intellectual Property Issues 45
Pricing Regime 47
Reimbursement Regime 48
Market Overview 49
Healthcare Sector 50
Research and Development 52
Clinical Trials 54
Epidemiology 55
Competitive Landscape 58
Research-Based Industry 58
Table: Multinational Market Activity 60
Generic Drugmakers 61
Pharmaceutical Distribution 62
Pharmaceutical Retail 63
Company Profile 65
GlaxoSmithKline 65
Groupe Saidal 67
Merck and Co 71
Novartis 73
Pfizer 75
Sanofi 77
Demographic Forecast 81
Demographic Outlook 81
Table: Population Headline Indicators (Algeria 1990-2025) 82
Table: Key Population Ratios (Algeria 1990-2025) 82
Table: Urban/Rural Population and Life Expectancy (Algeria 1990-2025) 83
Table: Population By Age Group (Algeria 1990-2025) 83
Table: Population By Age Group % (Algeria 1990-2025) 84
Glossary 86
Methodology 88
Pharmaceutical Expenditure Forecast Model 88
Healthcare Expenditure Forecast Model 88
Notes On Methodology 89
Risk/Reward Index Methodology 90
Index Overview 91
Table: Pharmaceutical Risk/Reward Index Indicators 91
Indicator Weightings 92

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.